Akhmal Yusof – CEO, Clinical Research Malaysia (CRM)
Dr Akhmal Yusof, CEO of CRM sheds light on the capacity for all stages of clinical research in Malaysia. He discusses the importance of human resources for the country’s research…
Clinical Research Malaysia (CRM) is a non-profit organization wholly owned by the Government of Malaysia. It was established in June 2012 to promote Malaysia as a preferred global destination for industry sponsored clinical research (ISR). CRM provides a range of services to enable and facilitate sponsors (primarily from the pharmaceutical and medical device industries) and contract research organizations (CROs) to initiate a wide spectrum of clinical trials in Malaysia.
CRM’s key functions encompasses three core components, the first of which is securing clinical trials. This is done through advertising and promotional activities, participation in key conferences, involvement in clinical trial distribution and strategic collaborations with major stakeholders. The second component involves closing the deals through a comprehensive feasibility study, convincing site review operation and implementation of an efficient financial, administration and approval process. The third component is conducting the trials. This is achieved through our high quality Study Coordinators and Principal Investigators, effective standard operating procedures, quality assurance of study sites and support services.
CRM Contact Details
Clinical Research Malaysia
Suite E-10-20, Amcorp Business Suites, Menara Melawangi,
Amcorp Trade Centre, No.18, Jalan Persiaran Barat,
46050 Petaling Jaya, Selangor Darul Ehsan, Malaysia.
T: +603 7960 5153
F: +603 7932 1940
E: contact@clinicalresearch.my
W: www.clinicalresearch.my
Get connected socially,
facebook.com/clinicalresearchmalaysia
twitter.com/clinicalrsrchmy
youtube.com/ClinicalRsrchMy
linkedin.com/company/clinical-research-malaysia
Dr Akhmal Yusof, CEO of CRM sheds light on the capacity for all stages of clinical research in Malaysia. He discusses the importance of human resources for the country’s research…
Clinical Research Malaysia’s CEO discusses the need for Malaysia to focus on high quality pivotal trials rather than simply on a high number of trials. He shares with us the…
Cliford Patrick, regional vice president listings at MIMS expands on the opportunities that data can bring to healthcare in Malaysia, from improving patient safety, to streamlining the healthcare budget. Patrick…
Saravanan G., group managing director of Biocare Group, details the opportunities he identified to create the first MDI (Metered Dose Inhalers) manufacturing plant in Malaysia. He also explains further the…
Siobhan Das, executive director of the American Malaysian Chamber of Commerce, discusses the close business ties between the two countries and the future opportunities that exist for further investment growth…
Ch’ng Kien Peng, executive director of Xepa-Soul Pattinson, offers insights on the dynamic healthcare industry in Malaysia and the new government’s key role in supporting the local industry. He also…
Indranil Sen, managing director of Ranbaxy Malaysia, a Sun Pharma company, discusses the role of generics in the Malaysian pharmaceutical sector, and their strategy to lead the market, rather than…
Javed Ghulam, CEO of AJ Research & Pharma, offers insights into the dynamic pharma industry in Malaysia and what it takes to be a competitive player in the region. …
Billy Urudra, president of the Malaysian Organisation of Pharmaceutical Industries, highlights the major trends and challenges in the Malaysian pharmaceutical industry, especially for generics players and touches upon the potential…
Lance Duan, general manager of Roche Malaysia, discusses the dynamic changes in the country’s health system and the possibilities that exist for Roche to establish a collaborative relationship with the…
Dr. Saunthari Somasundaram walks us through the NCSM’s mission to raise awareness on cancer prevention and early diagnosis in Malaysia. She details the need for more government support to make…
Jamaludin Elis, country CEO of Chulia Life Sciences Sdn Bhd, discusses the diverse activities of Chulia Group’s various subsidiaries, as well as the group’s upcoming projects in the healthcare industry.…
Following the death penalty handed to Muhammad Lukman, a 29-year old man who was convicted of possessing, processing and distributing medicinal cannabis oil, public outcry has caused Malaysian officials to reconsider the punishment. Muhammad…
Roberto Benetello, CEO of the EU-Malaysia Chamber of Commerce and Industry (EUMCCI), discusses the chamber’s function in Malaysia, the current business environment of the country, and the upcoming changes that…
See our Cookie Privacy Policy Here